Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtronic Puts Its Muscle Behind AEDs

Executive Summary

Medtronic is buying Physio-Control International, the leading maker of external defibrillators for hospital and out-of hospital applications. The big attraction for Medtronic is Physio-Control's automatic external defibrillators, which are simple-to-use external defibrillators, designed to allow minimally trained or untrained peole to provide quick help to victims of sudden cardiac death. Medtronic wants to increase the extremely low survival rate of SCD victims because they can then become candidates for Medtronic's implantable defibrillators. Physio Control on the other hand, while the market leader in this field, needs Medtronic's resources and access to cardiologists in order to quicken the pace of the market development in this field. Moreover, Physio-Control, while successful, is a narrowly focused company, which has made its stock more volatile than is warranted.

Related Content


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts